Self-Limited Familial Neonatal-Infantile Epilepsy

Self-limited familial neonatal-infantile epilepsy (SeLFNIE) is an inherited focal epilepsy syndrome in which seizures begin at different ages across the neonatal and early infantile period, often within the same family, and then remit during infancy or early childhood.

The syndrome is most strongly associated with pathogenic variants in SCN2A, although other genes can produce overlapping phenotypes.

Why the name includes both neonatal and infantile

In one family, one child may develop seizures in the neonatal period while another relative begins several months later.

This variation in age at onset distinguishes SeLFNIE from syndromes confined more tightly to the neonatal or infantile period.

What the seizures look like

Seizures are focal and often brief. Motor features can include tonic or clonic movements, sometimes with autonomic changes.

Different seizures in the same infant can arise from different regions, but the ictal EEG does not show the characteristic within-seizure migrating pattern seen in epilepsy of infancy with migrating focal seizures.

Development

Development is expected to remain normal in classic SeLFNIE.

Developmental slowing, neurological abnormalities or persistent drug-resistant seizures should prompt evaluation for a more severe SCN2A-related developmental and epileptic encephalopathy or another genetic disorder.

EEG

The background EEG is usually normal. Interictal epileptiform abnormalities may be absent between seizures.

Persistent focal slowing in one region raises concern for a structural brain abnormality.

MRI

Neuroimaging should not show a causal lesion.

If the electroclinical pattern is typical and a known familial pathogenic variant has been identified, MRI may not always be essential, but practice varies with age, setting and clinical confidence.

SCN2A

SCN2A encodes the Nav1.2 neuronal sodium-channel subunit.

Pathogenic variants can cause several different neurological phenotypes, ranging from self-limited neonatal-infantile epilepsy to severe developmental and epileptic encephalopathy, autism or intellectual disability.

Why functional effect matters

In SCN2A-related disease, the effect of a variant on channel function can influence both phenotype and potential treatment response.

Early-onset epilepsies are often associated with gain-of-function mechanisms, while some later neurodevelopmental phenotypes involve loss of function. This is an evolving precision-medicine area and should not be reduced to a simple gene-equals-drug rule.

Other genes

Overlapping self-limited neonatal-infantile phenotypes can occur with variants in genes including KCNQ2, SCN8A and PRRT2.

Genetic testing is therefore usually performed with a multigene or genomic approach rather than by assuming one gene from age alone.

Treatment

Many infants respond well to antiseizure treatment, and seizures typically remit.

Sodium-channel-blocking medicines may be effective in some early-onset SCN2A gain-of-function epilepsies, but treatment should be guided by the full phenotype and specialist interpretation.

Family history

The syndrome is usually autosomal dominant. A family history of neonatal or infantile seizures that resolved can be a major diagnostic clue.

Incomplete penetrance and de novo variants mean that family history may still be negative in some affected infants.

Distinguishing SeLFNIE from self-limited neonatal epilepsy

The main distinction is the age range. SeLNE is concentrated in the neonatal period, whereas SeLFNIE can begin anywhere from neonatal life into early infancy within the same family.

Distinguishing SeLFNIE from self-limited infantile epilepsy

Self-limited infantile epilepsy usually begins later in infancy, commonly around several months of age, and is often associated with PRRT2.

Again, age is only one clue; the family pattern and genetic result are important.

Distinguishing SeLFNIE from EIMFS

Epilepsy of infancy with migrating focal seizures causes severe developmental impairment and an EEG pattern in which seizure activity migrates between cortical regions during the same seizure.

That migrating electrographic pattern is not a feature of classic SeLFNIE.

Worldwide access

In settings without rapid genomics, diagnosis may remain clinical and familial. This can be challenging when relatives do not know the details of neonatal events from previous generations.

Genetic confirmation can reduce uncertainty and clarify recurrence risk when available.

The central point

SeLFNIE is a self-limited inherited focal epilepsy whose hallmark is variation in seizure onset from the neonatal period into infancy within families. It should be separated from severe migrating-focal-seizure syndromes and from SCN2A developmental encephalopathy.

Sources

Medical note: genetic interpretation should be phenotype-specific. The same epilepsy gene can produce self-limited or severe disease depending on the variant and mechanism.

Evidence checked: September 2026.